SCHEMBL22620113

SCHEMBL22620113

N#CCC(=O)N1CCC[C@@H](N)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK3 P52333 15/20 0.44
JAK2 O60674 14/20 0.44
JAK1 P23458 9/20 0.44
KDM1A O60341 3/20 0.42
ALDH1A1 P00352 2/20 0.42
MEN1 O00255 1/20 0.42
MAPT P10636 1/20 0.42
KMT2A Q03164 1/20 0.42
TYK2 P29597 6/20 0.41
ROCK2 O75116 2/20 0.39
MARK3 P27448 2/20 0.39
PRKCD Q05655 2/20 0.39
STK3 Q13188 2/20 0.39
ROCK1 Q13464 2/20 0.39
CAMK2D Q13557 2/20 0.39
PKN2 Q16513 2/20 0.39
LRRK2 Q5S007 2/20 0.39
MARK2 Q7KZI7 2/20 0.39
MAP4K3 Q8IVH8 1/20 0.39
MAP4K5 Q9Y4K4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13724137 1.00 JAK3 (0.44) JAK3JAK2JAK1KDM1AALDH1A1
SCHEMBL19014106 0.82 MCL1 (0.39) JAK3JAK2JAK1KDM1AALDH1A1
SCHEMBL18525632 0.81 CHRM2 (0.44) JAK3JAK2JAK1ALDH1A1MEN1
SCHEMBL20183292 0.80 ALDH1A1 (0.42) JAK3JAK2JAK1ALDH1A1MEN1
SCHEMBL12957767 0.80 ALDH1A1 (0.63) ALDH1A1MEN1MAPTKMT2ALMNA
SCHEMBL14644693 0.80 ALDH1A1 (0.63) ALDH1A1MEN1MAPTKMT2ALMNA
SCHEMBL14426034 0.80 ALDH1A1 (0.63) ALDH1A1MEN1MAPTKMT2ALMNA
SCHEMBL3428769 0.79 ALDH1A1 (0.43) JAK3JAK2JAK1KDM1AALDH1A1
SCHEMBL13723895 0.79 GNAI3 (0.47) JAK3JAK2JAK1KDM1AALDH1A1
SCHEMBL22370793 0.79 JAK2 (0.47) JAK3JAK2JAK1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020223728-A1 SUBSTITUTED PYRROLOPYRIDINES AS JAK INHIBITORS ACLARIS THERAPEUTICS, INC. (US) 2020-11-05 WO disclosed